Literature DB >> 24865449

Friend or foe? IgLON5 antibodies in a novel tauopathy with prominent sleep movement disorder, ataxia, and chorea.

Bettina Balint1, Kailash P Bhatia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24865449     DOI： 10.1002/mds.25926

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  Isolated dysphagia as initial sign of anti-IgLON5 syndrome.

Authors:  Jens Burchard Schröder; Nico Melzer; Tobias Ruck; Anna Heidbreder; Ilka Kleffner; Ralf Dittrich; Paul Muhle; Tobias Warnecke; Rainer Dziewas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-11-22

2.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

3.  Lewy Body Dementia Associated with Anti-IgLON 5 Encephalitis Detected on 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and 99mTc-TRODAT Single-Photon Emission Computed Tomography/Computed Tomography.

Authors:  Nikhil Seniaray; Ritu Verma; Rajeev Ranjan; Ethel Belho; Harsh Mahajan
Journal:  Indian J Nucl Med       Date:  2022-03-25

Review 4.  The non-Huntington disease choreas: Five new things.

Authors:  Ruth H Walker
Journal:  Neurol Clin Pract       Date:  2016-04

Review 5.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.